[Ip-health] Query - Malaria, Big Drugs and Big Bucks, African Babies as Guinea Pigs?
Riaz K Tayob
riaz.tayob at gmail.com
Wed Feb 8 14:11:25 PST 2012
[Is this true?]
February 08, 2012
Malaria, Big Drugs and Big Bucks
African Babies as Guinea Pigs?
by THOMAS C. MOUNTAIN
When it comes to the new malaria vaccine developed by GlaxoSmithKline
(GSK) now being tested on infants in the east African country of
Tanzania I will let the words of an industry insider tell it best:
"There is not much profit to be made by big pharma from a highly
effective malaria vaccine of practical use for African
sufferers...they [Big Drugs) are fiendishly clever at exploiting any
and all opportunities to reap big benefits."
"The poorly performing malaria vaccine RTS,S, created by GSK with a
healthy infusion of funds from the Gates Foundation, is being tested
in Phase III trials in Africa now. Including many thousands of
"GSK will not profit from RTS,S. However, RTS,S is injected along
with a new GSK adjuvant called AS01."
"GSK will make vast sums from the new adjuvant, the testing of which
is being piggybacked on their altruistic malaria vaccine (which,
incidentally, is virtually entirely ineffective without AS01)."
"Interestingly, RTS,S (or should I say, AS01) testing in African
infants began before AS01 trials in children were permitted in the
"GSK physician-scientists also held positions of significance in the
Gates Foundation...conflict-of-interest issues not withstanding."
So the Gates Foundation is giving Big Bucks ($400 million and counting)
to Big Drugs/GSK to develop a vaccine against Africa's number one
The new not-for-profit malaria vaccine is "virtually entirely
ineffective" without another medicine, whose patent is owned by GSK,
resulting in $billions of African blood money filling the coffers of Big
Drugs, once again.
Never mind Big Drugs/GSK had its reps at the Gate$ Foundation and Big
Buck$ in the form of tax deductible grants are being shelled out by the
Gate$ Foundation to Big Drugs/GSK.
And never mind that billions of desperately needed African foreign
currency reserves will be spent on this new malaria vaccine. The really
nasty thing about all this is the fact that, once again, Big Drugs tests
new drugs on African babies before any such permission is granted to do
so on American babies.
And all the while one African country, Eritrea, has reduced malaria
mortality by 80% over the last decade, a fact unknown to the supposedly
altruistic, or more aptly, incestuous, vaccine industry.
/*Thomas C. Mountain* is the only independent western journalist in the
Horn of Africa, living and reporting from Eritrea since 2006. He can be
reached at thomascmountain at yahoo dot com.
More information about the Ip-health